GUIRADO PERICH, LLUIS F. PUIGVERT
lguirado@fundacio-puigvert.es
Ars Criach, Elisabeth F. PUIGVERT
Ayasreh Fierro, Nadia F. PUIGVERT
Ballart Roig, Judith F. PUIGVERT
Bardaji De Quixano, Beatriz F. PUIGVERT
Canal Girol, Cristina F. PUIGVERT
Coll Piera, Elisabet F. PUIGVERT
Diaz Encarnacion, Montserrat Mercedes F. PUIGVERT
Dominguez Guasch, Anna F. PUIGVERT
Fernandez De La Llama, Patricia F. PUIGVERT
Furlano, Monica Maria F. PUIGVERT
Garcia Manau, Pablo IR
Lloret Cora, Maria Jesus F. PUIGVERT
Marco Rusiñol, Helena F. PUIGVERT
Mateu Escudero, Silvia F. PUIGVERT
Pilco Teran, Melissa Lorena IR
Pybus Oliveras, Marc F. PUIGVERT
Sanmiguel Amigo, Luz F. PUIGVERT
Silva Torres, Irene F. PUIGVERT
Tinoco Aranda, Adria P. IR
Torra Balcells, Roser F. PUIGVERT
Viera Ramirez, Elizabeth R. F. PUIGVERT
(JIF 2024)
-Arias M, González JC, Betancourt L, Coll E, Collado S, Romano B, Lupiañez A, Garro J, Duarte V, Soler J, Calabia J. Intradialytic Parenteral Nutrition in Patients on Hemodialysis: A Multicenter Retrospective Study. Nutrients. 2024; 16(23):4018. DOI:10.3390/nu16234018. PMID:39683411. IF:5,000 (Q1/2D). Document type: Article.
-Bais T, Meijer E, Kramers BJ, Vart P, Vervloet M, Salih M, Bammens B, Demoulin N, Todorova P, Müller RU, Halbritter J, Paliege A, Gall E, Knebelmann B, Torra R, Ong A, Frankl F, Gansevoort RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1):120. DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2,000 (Q3/7D). Document type: Article.
-Basile G, Pecoraro A, Gallioli A, Territo A, Berquin C, Robalino J, Bravo A, Huguet J, Rodriguez O, Gavrilov P, Facundo C, Guirado L, Gaya JM, Palou J, Breda A. Robotic kidney transplantation. Nature Reviews Urology. 2024; 21(9). DOI:10.1038/s41585-024-00865-z. PMID:38480898. IF:14,600 (Q1/1D). Document type: Review.
-Blasco M, Quiroga B, García JM, Castro C, Fernández SJ, Luna E, Fresnedo GF, Ossorio M, Izquierdo MJ, Sanchez D, Castañeda L, Mouzo R, Cao M, Besada ML, Pan R, Torra R, Ortiz A, de Sequera P, GENSEN I. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study. AMERICAN JOURNAL OF KIDNEY DISEASES. 2024; 84(6). DOI:10.1053/j.ajkd.2024.04.021. PMID:38972501. IF:8,200 (Q1/1D). Document type: Article.
-Blasco M, Quiroga B, García JM, Torra R, Ortiz A, de Sequera P. Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN. NEFROLOGIA. 2024; 44(4). DOI:10.1016/j.nefro.2023.09.002. PMID:39054238. IF:2,600 (Q2/4D). Document type: Article.
-Bover J, Gómez C, Casado E, Rodríguez M, Lloret MJ, Castro C, Gifre L, Henríquez F, Prior A, de la Manzanara VL, Láiz AM, Martínez A, Torregrosa JV, Cigarrán S, Górriz JL, Montomoli M, Panizo N, Costa E, Martínez D, Rodríguez M, Navarro JF. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. NEFROLOGIA. 2024; 44(2). DOI:10.1016/j.nefro.2023.05.00. IF:2,600 (Q2/4D). Document type: Article.
-Bover J, Gómez C, Casado E, Rodríguez M, Lloret MJ, Castro C, Gifre L, Henríquez F, Prior Á, López de la Manzanara V, Láiz AM, Martínez À, Torregrosa JV, Cigarrán S, Górriz JL, Montomoli M, Panizo N, Costa E, Martínez D, Rodríguez M, Navarro JF. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica. NEFROLOGIA. 2024; 44(2). DOI:10.1016/j.nefro.2023.05.002. PMID:38531765. IF:2,600 (Q2/4D). Document type: Article.
-Coll E, Cigarran S, Portolés J, Cases A. Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease. Toxins. 2024; 16(11):495. DOI:10.3390/toxins16110495. PMID:39591250. IF:4,000 (Q1/3D). Document type: Review.
-Dieguez L, Pilco M, Butori S, Kanashiro A, Balana J, Emiliani E, Somani BK, Angerri O. Dent’s Disease: A Cause of Monogenic Kidney Stones and Nephrocalcinosis. Journal of Personalized Medicine. 2024; 14(6):623. DOI:10.3390/jpm14060623. PMID:38929844. IF:3,000 (Q1/2D). Document type: Article.
-Draibe JB, Marco H, Ibernon M, Agraz I, Arcal C, Barros X, Cabrera V, Da I, Díaz M, Fulladosa X, Guillén E, Lescano P, Valenzuela LM, Márquez E, Martin N, Merino A, Navarro M, Rodríguez E, Soler MJ, Torras J, Quintana LF, Catalan N. Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT). Journal of Clinical Medicine. 2024; 13(22):6793. DOI:10.3390/jcm13226793. PMID:39597938. IF:2,900 (Q1/2D). Document type: Review.
-Duijzer R, Bernts LHP, Geerts A, van B, Coenraad MJ, Rovers C, Alvaro D, Kuijper EJ, Nevens F, Halbritter J, Colmenero J, Kupcinskas J, Salih M, Hogan MC, Ronot M, Vilgrain V, Hanemaaijer NM, Kamath PS, Strnad P, Taubert R, Gansevoort R, Torra R, Nadalin S, Suwabe T, Gevers TJG, Cardinale V, Drenth JPH, Lantinga MA. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework. Lancet Gastroenterology & Hepatology. 2024; 9(9). DOI:10.1016/S2468-1253(24)00094-3. PMID:38878785. IF:38,600 (Q1/1D). Document type: Review.
-El Bachouti J, Domínguez A, Arce Y, Oñate G, Marco H, Diaz M, Guirado L, Torra R, Barros X. Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome. Journal of Clinical Medicine. 2024; 13(21):6468. DOI:10.3390/jcm13216468. PMID:39518607. IF:2,900 (Q1/2D). Document type: Article.
-Fraga G, Herreros MA, Pybus M, Aza M, Pilco M, Furlano M, García MJ, Torra R, Ars E. A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene. Genes. 2024; 15(6):679. DOI:10.3390/genes15060679. PMID:38927615. IF:2,800 (Q2/5D). Document type: Article.
-Furlano M, Pilco M, Pybus M, Martínez V, Aza M, Peris AR, Pérez V, Berná G, Mazon J, Hernández J, de Arizón LF, Viera E, Gich I, Pérez HV, Gomá E, Dolon J, Ars E, Torra R. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9). DOI:10.1093/ndt/gfae031. PMID:38317457. IF:5,600 (Q1/1D). Document type: Article.
-Gosselink ME, Snoek R, Cerkauskaite A, van SPJ, Vollenberg R, Groen H, Cerkauskiene R, Miglinas M, Attini R, Tory K, Claes KJ, van K, Servais A, de Jong MFC, Gillion V, Vogt L, Mastrangelo A, Furlano M, Torra R, Bramham K, Wiles K, Ralston ER, Hall M, Liu LS, Hladunewich MA, Lely AT, van AM, ALPART GRP. Reassuring pregnancy outcomes in women with mild COL4A3-5 – related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. KIDNEY INTERNATIONAL. 2024; 105(5). DOI:10.1016/j.kint.2024.01.034. PMID:38382843. IF:12,600 (Q1/1D). Document type: Article.
-Hughes DA, Sunder G, Jovanovic A, Brand E, West ML, Bichet DG, Pisani A, Nowak A, Torra R, Khan A, Azevedo O, Lehman A, Linhart A, Rutecki J, Giuliano JD, Krusinska E, Nordbeck P. Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry. JOURNAL OF INHERITED METABOLIC DISEASE. 2024; DOI:10.1002/jimd.12771. PMID:39031114. IF:3,800 (Q2/3D). Document type: Article.
-Jorgensen HS, Lloret MJ, Lalayiannis AD, Shroff R, Evenepoel P, European Renal Osteodystrophy EU, European Renal Assoc ERA GRP, Dialysis CKD-MBDGRP, European Soc Pediat N. Ten tips on how to assess bone health in patients with chronic kidney disease. Clinical Kidney Journal. 2024; 17(5):sfae093. DOI:10.1093/ckj/sfae093. PMID:38817914. IF:4,600 (Q1/2D). Document type: Article.
-Lloret MJ, Fusaro M, Jorgensen HS, Haarhaus M, Gifre L, Alfieri CM, Masso E, D’Marco L, Evenepoel P, Bover J. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 2024; 13(4):1010. DOI:10.3390/jcm13041010. PMID:38398323. IF:2,900 (Q1/2D). Document type: Review.
-Salgueira M, Almenara M, Gutierrez A, Belmar L, Labrador PJ, Melero R, Serrano ML, Portoles JM, Molina A, Poch E, Ramos N, Lloret MJ, Echarri R, Mancebo RD, Gonzalez DM, Sanchez JE, Soler MJ. Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data. NEFROLOGIA. 2024; 44(4). DOI:10.1016/j.nefro.2023.03.0080211-6995. IF:2,600 (Q2/4D). Document type: Article.
-Suarez R, Villarreal C, Nahuelpán Y, Jara C, Oyarzún C, Alarcón S, Díaz MM, Guillén E, Quezada C, San Martín R. Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024; 1870(1):166890. DOI:10.1016/j.bbadis.2023.166890. PMID:37734469. IF:4,200 (Q1/2D). Document type: Article.
-Taylor J, Thomas R, Metherall P, van M, Cornec E, Caroli A, Furlano M, Demoulin N, Devuyst O, Winterbottom J, Torra R, Perico N, Le Y, Schoenherr S, Forer L, Gansevoort RT, Simms RJ, Ong ACM. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD. Kidney International Reports. 2024; 9(2). DOI:10.1016/j.ekir.2023.10.029. PMID:38344736. IF:5,700 (Q1/1D). Document type: Article.
(JIF 2023)
-Angerri O, Gracia S, Rousaud F, Kanashiro A, Emiliani E. Entering into 2.0 cystinuria management with a medical digital tool to monitor urine pH: A prospective, randomized study. Actas Urologicas Espanolas. 2023; 47(9). DOI:10.1016/j.acuro.2023.02.004. IF:1,200 (Q3/8D). Document type: Article.
-Bermejo S, González E, López K, Ibernon M, López D, Martín A, Garcia R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Bestard O, Praga M, Fulladosa X, Soler MJ. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes. Clinical Kidney Journal. 2023; 16(10). DOI:10.1093/ckj/sfad142. PMID:37779839. IF:3,900 (Q1/2D). Document type: Article.
-Bichet DG, Hopkin RJ, Aguiar P, Allam SR, Chien YH, Giugliani R, Kallish S, Kineen S, Lidove O, Niu DM, Olivotto I, Politei J, Rakoski P, Torra R, Tøndel C, Hughes DA. Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study. Frontiers in Medicine. 2023; 10:1220637. DOI:10.3389/fmed.2023.1220637. PMID:37727761. IF:3,100 (Q1/2D). Document type: Article.
-Caravaca F, Cavero T, Díaz M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez N, Cruz S, Fernández G, Rodríguez A, Pérez De José A, Rabasco C, Rodado R, Fernández L, Pérez V, Ávila A, Bravo L, Espinosa N, Allende N, Sanchez De La Nieta MD, Rodríguez E, Rivas B, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, De Lorenzo A, Draibe J, González F, Shabaka A, López ME, Fenollosa MÁ, Martín L, Da I, Titos JA, Rodríguez De Córdoba S, Goicoechea De Jorge E, Praga M. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy. Kidney360. 2023; 4(5). DOI:10.34067/KID.0000000000000115. PMID:36996481. IF:3,200 (Q1/2D). Document type: Article.
-de Sequera P, Perez R, Vega A, Martinez S, Acosta JG, Del Valle KP, Fernandez M, Garcia MA, Garcia AL, Coll E, Merida E, Martinez P, Castano I, Gil B, Garro J, Maduel F, MOTheR N. Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration. Clinical Kidney Journal. 2023; 16(11). DOI:10.1093/ckj/sfad128. PMID:37915938. IF:3,900 (Q1/2D). Document type: Article.
-Doyágüez PR, Boldoba NB, Gimena R, Sevillano BH, Ballcells RT. Renal involvement in rare genetic diseases. Medicine (spain). 2023; 13(79). DOI:10.1016/j.med.2023.05.004. Document type: Article.
-Fayos De Arizón L, Viera ER, Pilco M, Perera A, De Maeztu G, Nicolau A, Furlano M, Torra R. Artificial intelligence: a new field of knowledge for nephrologists? Clin Kidney J. 2023; 16(12):2314-2326. DOI: 10.1093/ckj/sfad182. PMID: 38046016. IF:3,900 (Q1/2D). Document type: Review.
-Garcia A, de la Flor JC, Coll E, Iglesias E, Reque J, Valga F. Expanded hemodialysis: what’s up, Doc?. Clinical Kidney Journal. 2023; 16(7). DOI:10.1093/ckj/sfad033. PMID:37398691. IF:3,900 (Q1/2D). Document type: Review.
-Huerta A, Arjona E, Portoles J, Lopez P, Cavero T, Fernandez J, Blasco M, Cabello V, Calvo N, Diaz M, Herrero M, Aguirre M, Elías S, Alcaide MP, Ramos N, Sellares J, Rodríguez de Córdoba S. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4). DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14,800 (Q1/1D). Document type: Article.
-Hughes DA, Bichet DG, Giugliani R, Hopkin RJ, Krusinska E, Nicholls K, Olivotto I, Feldt U, Sakai N, Skuban N, Sunder G, Torra R, Wilcox WR. Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes. JOURNAL OF MEDICAL GENETICS. 2023; 60(7). DOI:10.1136/jmg-2022-108669. PMID:36543533. IF:3,500 (Q2/4D). Document type: Article.
-Jankowska M, Soler MJ, Stevens KI, Torra R. Why do we keep ignoring sex in kidney disease? Clin Kidney J. 2023; 16(12):2327-2335. DOI: 10.1093/ckj/sfad183. PMID: 38046033. IF:3,900 (Q1/2D). Document type: Review.
-Kiryluk K, Sanchez E, Zhou XJ, Zanoni F, Liu LL, Mladkova N, Khan A, Marasa M, Zhang JY, Balderes O, Sanna S, Bomback AS, Canetta PA, Appel GB, Radhakrishnan J, Trimarchi H, Sprangers B, Cattran DC, Reich H, Pei YR, Ravani P, Galesic K, Maixnerova D, Tesar V, Stengel B, Metzger M, Canaud G, Maillard N, Berthoux F, Berthelot L, Pillebout E, Monteiro R, Nelson R, Wyatt RJ, Smoyer W, Mahan J, Samhar A, Hidalgo G, Quiroga A, Weng PTC, Sreedharan R, Selewski D, Davis K, Kallash M, Vasylyeva TL, Rheault M, Chishti A, Ranch D, Wenderfer SE, Samsonov D, Claes DJ, Akchurin O, Goumenos D, Stangou M, Nagy J, Kovacs T, Fiaccadori E, Amoroso A, Barlassina C, Cusi D, Del Vecchio L, Battaglia GG, Bodria M, Boer E, Bono L, Boscutti G, Caridi G, Lugani F, Ghiggeri G, Coppo R, Peruzzi L, Esposito V, Esposito C, Feriozzi S, Polci R, Frasca G, Galliani M, Garozzo M, Mitrotti A, Gesualdo L, Granata S, Zaza G, Londrino F, Magistroni R, Pisani I, Magnano A, Marcantoni C, Messa P, Mignani R, Pani A, Ponticelli C, Roccatello D, Salvadori M, Salvi E, Santoro D, Gembillo G, Savoldi S, Spotti D, Zamboli P, Izzi C, Alberici F, Delbarba E, Florczak M, Krata N, Mucha K, Paczek L, Niemczyk S, Moszczuk B, Panczyk M, Mizerska M, Perkowska A, Baczkowska T, Durlik M, Pawlaczyk K, Sikora P, Zaniew M, Kaminska D, Krajewska M, Kuzmiuk I, Heleniak Z, Bullo B, Liberek T, Debska A, Hryszko T, Materna A, Miklaszewska M, Szczepanska M, Dyga K, Machura E, Siniewicz K, Pawlak M, Tkaczyk M, Runowski D, Kwella N, Drozdz D, Habura I, Kronenberg F, Prikhodina L, van D, Fontaine B, Cotsapas C, Wijmenga C, Franke A, Annese V, Gregersen PK, Parameswaran S, Weirauch M, Kottyan L, Harley JB, Suzuki H, Narita I, Goto S, Lee HJ, Kim DK, Kim YS, Park JH, Cho BL, Choi M, Van A, Huerta A, Ars E, Ballarin J, Lundberg S, Vogt B, Mani LY, Caliskan Y, Barratt J, Abeygunaratne T, Kalra PA, Gale DP, Panzer U, Rauen T, Floege J, Schlosser P, Ekici AB, Eckardt KU, Chen N, Xie JY, Lifton RP, Loos RJF, Kenny EE, Ionita I, Kottgen A, Julian BA, Novak J, Scolari F, Zhang H, Gharavi AG. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. NATURE GENETICS. 2023; 55(7). DOI:10.1038/s41588-023-01422-x. PMID:37337107. IF:31,700 (Q1/1D). Document type: Article.
-Lopez SC, Downie ML, Kim JS, Boyer O, Walsh SB, Nijenhuis T, Papizh S, Yadav P, Reynolds B, Decramer S, Besouw M, Carrascosa MP, La Scola C, Trepiccione F, Ariceta G, Hummel A, Dossier C, Sayer JA, Konrad M, Keijzer MG, Awan A, Basu B, Chauveau D, Madariaga L, Koster L, Furlano M, Zacchia M, Marzuillo P, Tse Y, Dursun I, Pinarbasi AS, Tramma D, Hoorn EJ, Gokce I, Nicholls K, Eid LA, Sartz L, Riordan M, Hooman N, Printza N, Bonny O, Sancho PA, Schild R, Sinha R, Guarino S, Jimenez VM, Peña LR, Belge H, Devuyst O, Wlodkowski T, Emma F, Levtchenko E, Knoers N, Bichet DG, Schaefer F, Kleta R, European C, Bockenhauer D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10). DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4,800 (Q1/1D). Document type: Article.
-Lopez V, Mazuecos A, Villanego F, Alonso A, Beneyto I, Crespo M, Diaz C, Franco A, Gonzalez F, Guirado L, Jimenez C, Juega J, Llorente S, Paul J, Rodriguez A, Ruiz JC, Sanchez A, Torregrosa V, Rodrigo E, Hernandez D, Lopez V, Lopez M, Zarraga S, GDGYS. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients. NEFROLOGIA. 2023; 43(5). DOI:10.1016/j.nefro.2022.11.001. PMID:37957107. IF:2,000 (Q2/5D). Document type: Review.
-Macia M, Díaz M, Solans R, Mallol EP, Castells AG, Escribano C, de Arellano AR. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 2023; DOI:10.1080/14737167.2023.2297790. PMID:38126738. IF:1,800 (Q3/6D). Document type: Article.
-Martinez V, Furlano M, Sans L, Pulido L, Garcia R, Perez MV, Sanchez J, Blasco M, Castro C, Fernandez G, Robles NR, Valenzuela MP, Naranjo J, Martin N, Pilco M, Agraz I, Gonzalez JD, Panizo N, Fraga G, Fernandez L, Lopez MT, Dall’Anese C, Ortiz A, Torra R, Marcas L, Rius A, Tomas P, Garcia L, Luna E, Martin MA, Inigo P, Martins J, Ramos F, Garcia R, Garcia LD, Merino MD, Fernandez MJ, Madariaga L, Canal C, Martinez AM, Echarri R, Bouarich H, Cabezas A, R. Autosomal dominant polycystic kidney disease in young adults. Clinical Kidney Journal. 2023; 16(6). DOI:10.1093/ckj/sfac251. PMID:37260991. IF:3,900 (Q1/2D). Document type: Article.
-Mayayo C, Prat E, Vecino M, González L, Gràcia S, San Miguel L, Lopera N, Arias A, Artuch R, de Heredia ML, Torrecilla C, Rousaud F, Angerri O, Errasti E, Nunes V. Exploring the Contribution of the Transporter AGT1/rBAT in Cystinuria Progression: Insights from Mouse Models and a Retrospective Cohort Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(24):17140. DOI:10.3390/ijms242417140. PMID:38138969. IF:4,900 (Q1/3D). Document type: Article.
-Ortiz A, Ars E, Bernis C, Fraga G, Furlano M, Martinez V, Martins J, Perez MV, Rodriguez JC, Sans L, Torra R. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. NEFROLOGIA. 2023; 43(1). DOI:10.1016/j.nefro.2022.07.002. PMID:37217372. IF:2,000 (Q2/5D). Document type: Letter.
-Porrini E, Perez NM, Diaz JM, Lauzurrica R, Rodriguez JO, Torres IS, Moreso F, Garrit JMC, Ruiz RB, Vilaro MI, Lima MXM, Ramchand SK, Ruiz JC, de los Rios FG, Alvarez CR, Guindo MDD, Macias M, Vela DB, Osuna A, Bayes B, Sanchez CA, Ruiz MD, Rodriguez A, Rollan RD, Rinne FG, Sosa AJ, Mallen PD, Rinne AG, Miranda DM, Torres A. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(6). DOI:10.1093/ndt/gfac291. PMID:36323457. IF:4,800 (Q1/1D). Document type: Article.
-Rodriguez D, Broseta JJ, Bastida C, Alvarez MI, Nicolau C, Alvarez C, Agraz I, Sanchez M, Furlano M, Ruiz C, Quintana LF, Pineiro GJ, Poch E, Torra R, Blasco M. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment. NEPHRON. 2023; 147(3-4). DOI:10.1159/000526368. PMID:36088902. IF:2,300 (Q2/5D). Document type: Article.
-Sánchez R, Ripoll T, López M, de Juan J, Gimeno JR, Hermida Á, Ruz MA, Torregrosa JV, Mora A, García JM, Fortuny E, Aguinaga A, Torra R. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants. Orphanet Journal of Rare Diseases. 2023; 18(1):8. DOI:10.1186/s13023-022-02599-w. PMID:36624527. IF:3,400 (Q2/4D). Document type: Article.
-Sanz I, Angerri O, Baboudjain M, Kanashiro A, Gracia S, Millan F, Sanchez F, Somani B, Galan JA, Barghouthy Y, Emiliani E. Role, Cost, and Availably of Urinary pH Monitoring for Kidney Stone Disease-A Systematic Review of the Literature. Current Urology Reports. 2023; 24(8). DOI:10.1007/s11934-023-01166-5. PMID:37314611. IF:2,500 (Q2/4D). Document type: Review.
-Sevillano AM, Caravaca F, Garcia LC, Fernandez G, Lopez K, Guzman DA, Martin G, Quintana LF, Rodas LM, de la Nieta MDS, Rabasco C, Espinosa M, Diaz M, San Miguel L, Barrios C, Rodriguez E, Garcia P, Valera A, Pena JK, Shabaka A, Velo M, Sierra M, Gonzalez F, Fernandez MJ, Heras M, Delgado P, Gutierrez E, Moreno JA, Praga M, Spanish Study Glomerular Dis GRP. Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy. Kidney International Reports. 2023; 8(8). DOI:10.1016/j.ekir.2023.05.027. PMID:37547537. IF:5,700 (Q1/1D). Document type: Article.
-Stevens KI, Mallamaci F, Ortiz A, Bover J, Delanaye P, Torra R, Cozzolino M. ‘The forgotten sex’: gender disparities in kidney disease. Clinical Kidney Journal. 2023; DOI:10.1093/ckj/sfad102. IF:3,900 (Q1/2D). Document type: Editorial Material.
-Torra R, Kronbichler A, Bajema IM. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!. Clinical Kidney Journal. 2023; 17(1). DOI:10.1093/ckj/sfad250. PMID:38186890. IF:3,900 (Q1/2D). Document type: Editorial Material.
(JIF 2022)